CJC-1295 -5mg (No DAC) + IPA-5mg

CJC-1295 (Without DAC) – 5 mg + Ipamorelin – 5 mg

Research Use Only / Not for Human or Veterinary Use

This product consists of two separate synthetic peptide sequences, CJC-1295 (without DAC) and Ipamorelin, each characterized by a defined amino acid structure and described in scientific and biochemical literature. These materials are supplied exclusively for controlled laboratory research and analytical reference purposes and are not intended for clinical, therapeutic, consumer, or pharmaceutical use.

Each peptide is provided as a chemically characterized, lyophilized peptide powder, manufactured to internal research specifications and sealed to preserve chemical integrity during storage and handling. The 5 mg quantity of each compound is suitable for analytical reference work, structural comparison studies, and other non-clinical laboratory research applications in which peptide sequences are examined as independent reference materials.

This product is offered strictly for laboratory research and analytical use only and is not intended for human or animal consumption, administration, or exposure.

Technical Information

CJC-1295 (Without DAC)

CAS No. 863288-34-0

Chemical Description: CJC-1295 (synthetic peptide, no DAC modification)

Amino Acid Sequence:
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3367.97 g/mol

Purity: ≥99% (chemical purity)

Peptide Content: ≥80.0% (composition basis)

Acetate Content: <12.0%

Form: Solid, lyophilized powder

Ipamorelin

CAS No. 170851-70-4

Chemical Description: Ipamorelin (synthetic peptide)

Amino Acid Sequence: H-Aib-His-D-2-Nal-D-Phe-Lys-NH2

Molecular Formula: C₃₈H₄₉N₉O₅

Molecular Weight: ~711.85 g/mol

Purity: ≥99% (chemical purity)

Form: Solid, lyophilized powder

Certificate of Analysis (CoA): Available upon request

Analytical Scope & Limitations

Analytical characterization of these materials is limited to chemical identity, structure, composition, and purity testing only.

No sterility, endotoxin, bioburden, toxicology, pharmacokinetic, endocrine activity, immunogenicity, biological activity, or clinical safety studies have been performed.

As a result, human or animal exposure presents unknown and potentially serious risks.

Quality & Standards

At Altera Peptides Inc., products are sourced and handled with an emphasis on quality control, traceability, and reproducibility for research applications only. Internal standards are designed to support analytical consistency, not pharmaceutical, clinical, or therapeutic use.

Our commitment includes:

Controlled peptide synthesis processes

Batch consistency standards

Clear labeling and compliance practices

Secure packaging to maintain product integrity

Intended Use & Compliance

This product is provided strictly for laboratory research and analytical purposes only.

Not for use as:

A drug or pharmaceutical product

A dietary supplement

A cosmetic

A diagnostic, therapeutic, or clinical material

These products are not manufactured in compliance with Good Manufacturing Practice (GMP) requirements for human use and have not been approved, reviewed, or authorized by the FDA, Health Canada, EMA, or any other regulatory authority.

By purchasing this product, the buyer acknowledges and agrees that it is intended solely for non-medical, non-clinical research use by qualified personnel in appropriate laboratory environments.